Related Experiment Video
Updated: Mar 15, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Migraine
K R Peck1, Y L Johnson1, T A Smitherman1
1Department of Psychology, University of Mississippi, Oxford, MS, USA.
Abstract:
This chapter presents an overview of migraine epidemiology and mechanisms. Migraine is a common and disabling neurologic disorder characterized by episodic attacks of severe head pain and other symptoms, including interference with activity, nausea, and sensitivity to light and sound. A number of risk factors for migraine onset and progression have been identified, including the presence of comorbid disorders and overuse of acute headache medications. Though the pathophysiology of migraine is complex and incompletely understood, advances in genetics research and clinical trials methodology offer promise for better understanding the underlying pathophysiologic mechanisms. These advances presently center on genomewide studies, development of antibodies targeting calcitonin gene-related peptide, and understanding the psychologic mechanisms that underlie the efficacy of some interventions. Studies of both pharmacologic and behavioral interventions for migraine and its common comorbidities also offer promise for understanding the neuroepidemiologic mechanisms of migraine. Clinical trials relevant to these mechanisms are reviewed, and methodologic considerations for future trials are discussed.
Insights
Migraine is a disabling neurologic disorder. Advances in genetics, CGRP antibody development, and psychologic mechanisms offer new insights into migraine pathophysiology and treatment.
Area of Science:
- Neurology
- Neuroscience
- Epidemiology
Background:
- Migraine is a prevalent, disabling neurologic disorder marked by severe head pain and associated symptoms.
- Risk factors include comorbid conditions and acute medication overuse.
- Current understanding of migraine pathophysiology is incomplete.
Purpose of the Study:
- To provide an overview of migraine epidemiology and mechanisms.
- To highlight recent advances in understanding migraine pathophysiology.
- To review clinical trials and discuss future methodologic considerations.
Main Methods:
- Review of current literature on migraine epidemiology and pathophysiology.
- Discussion of advances in genetics research (GWAS).
- Examination of antibody development targeting calcitonin gene-related peptide (CGRP).
- Exploration of psychologic mechanisms and behavioral interventions.
- Analysis of clinical trials for pharmacologic and behavioral interventions.
Main Results:
- Identified risk factors for migraine onset and progression.
- Highlighted progress in understanding pathophysiologic mechanisms through genetics and CGRP research.
- Emphasized the role of psychologic factors in treatment efficacy.
- Reviewed existing clinical trials for interventions and comorbidities.
Conclusions:
- Advances in genetics, CGRP targeting, and psychologic research are improving the understanding of migraine.
- Further research and refined clinical trial methodologies are crucial for developing effective migraine treatments.
- Integrated approaches considering neuroepidemiologic and psychologic mechanisms are promising.
Related Concept Videos
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Migration
Pathophysiology of Vomiting
Mitral Valve Prolapse II: Assessment and Management
Cranial Nerves: Types Part I
Olfactory Nerve (Cranial Nerve I)
The olfactory nerve, or cranial nerve I, is unique as it is purely sensory and dedicated to the sense of smell. This nerve originates in the olfactory epithelium of the...
Narcolepsy

